Nonalcoholic fatty liver disease: a challenge for pediatricians (Q37788538)

23 August 2017

Nonalcoholic fatty liver disease: a challenge for pediatricians (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

23 August 2017

0 references

1 reference

1 reference

K Widhalm

1

1 reference

PubMed ID

20838401

23 August 2017

E Ghods

series ordinal

2

1 reference

PubMed ID

20838401

23 August 2017

language of work or name

English

0 references

publication date

14 September 2010

1 reference

International Journal of Obesity

23 August 2017

1 reference

23 August 2017

34

1 reference

23 August 2017

1451-1467

1 reference

23 August 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1038/ijo.2010.185

23 August 2017

0 references

cites work

The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Review article: diagnosis and treatment of non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Definitive diagnosis and assessment of risk for nonalcoholic fatty liver disease in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Elevated serum ALT in children presenting to the emergency unit: Relationship with NAFLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Onset of puberty and cardiovascular risk factors in untreated obese children and adolescents: a 1-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Clinical and histological features of nonalcoholic fatty liver disease in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Idiopathic steatohepatitis in childhood: a multicenter retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Prevalence of fatty liver in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

The relationship between fatty liver and hyperinsulinemia in obese Japanese children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Relationship between nonalcoholic fatty liver disease prevalence and visceral fat in obese adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Pediatric nonalcoholic fatty liver disease (NAFLD): a "growing" problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Histopathology of pediatric nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

The spectrum of fatty liver in obese children and the relationship of serum aminotransferases to severity of steatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Long-term follow-up of patients with NAFLD and elevated liver enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Pubertal alterations in growth and body composition. VI. Pubertal insulin resistance: relation to adiposity, body fat distribution and hormone release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

The metabolic syndrome and nonalcoholic fatty liver disease in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Dietary carbohydrate's effects on lipogenesis and the relationship of lipogenesis to blood insulin and glucose concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, and ameliorates steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Factors associated with insulin resistance and non-alcoholic fatty liver disease among youths.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Role of mitochondria in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

The ins and outs of mitochondrial dysfunction in NASH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

The role of cytokines and chemokines in the development of steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Non-alcoholic steatohepatitis: from cell biology to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Adipokines in liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Adiponectin levels are reduced in children born small for gestational age and are inversely related to postnatal catch-up growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Decreased serum adiponectin: an early event in pediatric nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Non invasive evaluation of liver fibrosis in paediatric patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Fructose, insulin resistance, and metabolic dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Fructose and carbonyl metabolites as endogenous toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Skeletal muscle insulin resistance: roles of fatty acid metabolism and exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

What have rare genetic syndromes taught us about the pathophysiology of the common forms of obesity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Disorders of glucose metabolism in sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Chronic liver injury during obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Risk for nonalcoholic fatty liver disease in Hispanic youth with BMI > or =95th percentile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Aspartate aminotransferase to platelet ratio index for fibrosis evaluation in chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Validation of three noninvasive laboratory variables to predict significant fibrosis and cirrhosis in patients with chronic hepatitis C in Saudi Arabia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Liver steatosis in obese prepubertal children: a possible role of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic Beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Distinguishing nonalcoholic steatohepatitis from fatty liver: serum-free fatty acids, insulin resistance, and serum lipoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

The utility of radiological imaging in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

MRI and ultrasound for hepatic fat quantification:relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Early heterogeneous enhancement of the liver: magnetic resonance imaging findings and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Evaluating the severity of nonalcoholic steatohepatitis with superparamagnetic iron oxide-enhanced magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

MRI in identifying hepatic steatosis in obese children and relation to ultrasonography and metabolic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Serum markers detect the presence of liver fibrosis: a cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

High sensitivity C-reactive protein values do not reliably predict the severity of histological changes in NAFLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Cytokeratin 18, a marker of cell death, is increased in children with suspected nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

A rabbit model of pediatric nonalcoholic steatohepatitis: the role of adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

FibroTest-ActiTest as a non-invasive marker of liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Treatment of non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Addition of orlistat to conventional treatment in adolescents with severe obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Role of aquaporin-7 in the pathophysiological control of fat accumulation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Liver histology changes in nonalcoholic steatohepatitis after one year of treatment with probucol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Nonalcoholic fatty liver disease decrease in obese adolescents after multidisciplinary therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Vitamin E treatment in pediatric obesity-related liver disease: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

A pilot trial of pentoxifylline in nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Underdiagnosis of pediatric obesity and underscreening for fatty liver disease and metabolic syndrome by pediatricians and pediatric subspecialists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Fuel selection in human skeletal muscle in insulin resistance: a reexamination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Effect of the volume and intensity of exercise training on insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Efficacy of exercise for treating overweight in children and adolescents: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Bariatric surgery for severely obese adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

An update on 73 US obese pediatric patients treated with laparoscopic adjustable gastric banding: comorbidity resolution and compliance data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Comparison of serum concentrations of alpha-tocopherol and beta-carotene in a cross-sectional sample of obese and nonobese children (NHANES III). National Health and Nutrition Examination Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

One-year outcomes of Roux-en-Y gastric bypass for morbidly obese adolescents: a multicenter study from the Pediatric Bariatric Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

Pathology of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

https://api.crossref.org/works/10.1038%2FIJO.2010.185

1 reference

7 January 2021

Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

Hepatic steatosis in obese Chinese children

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

Predictors of non-alcoholic fatty liver disease in obese children

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

The association between non-alcoholic fatty liver disease and insulin resistance in 20 obese children and adolescents

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

Tumor necrosis factor-alpha induces hepatic insulin resistance in obese Zucker (fa/fa) rats via interaction of leukocyte antigen-related tyrosine phosphatase with focal adhesion kinase

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

Steatohepatitis associated with limb lipodystrophy

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

Nonalcoholic steatohepatitis: risk factors for liver fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

Noninvasive in vivo quantitative assessment of fat content in human liver

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

Portal vein hemodynamics in patients with non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

Hepatic and portal vein flow pattern in correlation with intrahepatic fat deposition and liver histology in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

Nonalcoholic fatty liver disease in overweight children and adolescents

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

Imaging of nonalcoholic steatohepatitis: advantages and pitfalls of ultrasonography and computed tomography

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

Chronic hepatitis: correlation of early patchy and late linear enhancement patterns on gadolinium-enhanced MR images with histopathology initial experience

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

Computed Tomography Features of Nonalcoholic Steatohepatitis With Histopathologic Correlation

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

Adipokines and cytokines in non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

High-sensitivity C-reactive protein and metabolic syndrome (insulin resistance syndrome), including nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

Comparison of blood tests for liver fibrosis specific or not to NAFLD.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

Changes in serum adipokine levels during pioglitazone treatment for nonalcoholic steatohepatitis: relationship to histological improvement

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

Role of AMP-activated protein kinase in mechanism of metformin action

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

Resolution of nonalcoholic steatohepatits after gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.185

7 January 2021

Identifiers

DOI

10.1038/IJO.2010.185

1 reference

23 August 2017

1 reference

PubMed ID

20838401